Recommended Intake of Fish and Fish Oils Worldwide

Fish and Fish Oil in Health and Disease Prevention

Volumn , Issue , 2016, Pages 27-48

  Richter, C K ^a   Skulas Ray, A C ^b   Kris Etherton, P M ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Docosahexaenoic acid; Docosapentaenoic acid; Eicosapentaenoic acid; N 3 fatty acids; Seafood; Supplements

Indexed keywords

EID: 85018849607     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802844-5.00003-8     Document Type: Chapter

References (210)

1. Adarme-Vega T.C., et al. Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production. Microb. Cell Fact 2012, 11:96.
2. Amarin Corporation, 2015. Highlights of prescribing information, Vascepa.
3. ANSES, 2010. Avis de l'Agence francaise de securite sanitaire des aliments relatif a l'actualisation des apports ntritionnels conseilles pour les acides gras.
4. Araujo P., et al. Determination and structural elucidation of triacylglycerols in krill oil by chromatographic techniques. Lipids 2014, 49(2):163-172.
5. Arterburn L.M., et al. Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid. J. Am. Diet Assoc. 2008, 108(7):1204-1209.
6. Ashes J.R., et al. Incorporation of n-3 fatty acids of fish oil into tissue and serum lipids of ruminants. Lipids 1992, 27(8):629-631.
7. AstraZeneca, 2014. Highlights of prescribing information: Epanova.
8. Atkinson A., et al. Long-term decline in krill stock and increase in salps within the Southern Ocean. Nature 2004, 432(7013):100-103.
9. Australian National Health and Medical Research Council, 2006. Nutrient reference values for Australia and New Zealand including recommended dietary intakes.
10. Ballantyne C.M., et al. Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am. J. Cardiol. 2012, 110(7):984-992.
11. Bang H.O., Dyerberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta. Med. Scand. 1976, 200(1-2):69-73.
12. Bang H.O., Dyerberg J., Sinclair H.M. The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 1980, 33(12):2657-2661.
13. Bays H. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am. J. Cardiol. 2006, 98(4A):71i-76i.
14. Bays H.E., et al. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Am. J. Cardiol. 2011, 108(5):682-690.
15. Bellinger D.C. Mercury and pregnancy. Birth Defects Res. A: Clinical and Molecular Teratology 2014, 100(1):1-3.
16. Benistant C., et al. Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostagland. Leukot. Essent. Fatty Acid 1996, 55(4):287-292.
17. Berge K., et al. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Nutr. Res. 2014, 34(2):126-133.
18. Bernstein A.M., et al. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J. Nutr. 2012, 142(1):99-104.
19. Bloomingdale A., et al. A qualitative study of fish consumption during pregnancy. Am. J. Clin. Nutr. 2010, 92(5):1234-1240.
20. Brown A.J., Pang E., Roberts D.C. Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am. J. Clin. Nutr. 1991, 54(4):668-673.
21. Bunea R., El Farrah K., Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern. Med. Rev. 2004, 9(4):420-428.
22. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 2005, 45(5):581-597.
23. Burdge G.C., Jones A.E., Wootton S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br. J. Nutr. 2002, 88(4):355-363.
24. Cao J., et al. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin. Chem. 2006, 52(12):2265-2272.
25. Chee K.M., et al. Fatty acid content of marine oil capsules. Lipids 1990, 25(9):523-528.
26. Chopin T., et al. Integrating seaweeds into marine aquaculture systems: a key toward sustainability. J. Phycol. 2001, 37(6):975-986.
27. Cladis D.P., et al. Fatty acid profiles of commercially available finfish fillets in the United States. Lipids 2014, 49(10):1005-1018.
28. Conquer J.A., Holub B.J. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 1997, 32(3):341-345.
29. 2014. Product review: fish oil and omega-3 fatty acid supplements review (including krill, algae, calamari, green-lipped mussel oil). http://consumerlab.com.
30. Cosatto V.F., Else P.L., Meyer B.J. Do pregnant women and those at risk of developing post-natal depression consume lower amounts of long chain omega-3 polyunsaturated fatty acids?. Nutrients 2010, 2(2):198-213.
31. Crump K.S., et al. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal. 1998, 18(6):701-713.
32. Cunnane S., et al. Recommendations for intakes of polyunsaturated fatty acids in healthy adults. ISSFAL Newsl. 2004, 11(2):12-25.
33. Dai X.W., et al. Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women. Eur. J. Nutr. 2016, 981-989.
34. Dalli J., Colas R.A., Serhan C.N. Novel n-3 immunoresolvents: structures and actions. Sci. Rep. 2013, 3:1940.
35. Damude H.G., Kinney A.J. Engineering oilseed plants for a sustainable, land-based source of long chain polyunsaturated fatty acids. Lipids 2007, 42(3):179-185.
36. Dangi B., et al. Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6). J. Biol. Chem. 2009, 284(22):14744-14759.
37. Davidson M.H., et al. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova((R)) compared to Lovaza((R)) in a pharmacokinetic single-dose evaluation) study. J. Clin. Lipidol. 2012, 6(6):573-584.
38. Davis B.C., Kris-Etherton P.M. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am. J. Clin. Nutr. 2003, 78(3 (Suppl.)):640S-646S.
39. de Oliveira Otto M.C., et al. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the multi-ethnic study of atherosclerosis. J. Am. Heart Assoc. 2013, 2(6):pe000506.
40. Decker E.A., Akoh C.C., Wilkes R.S. Incorporation of (n-3) fatty acids in foods: challenges and opportunities. J. Nutr. 2012, 142(3):610S-613S.
41. Del Gobbo L.C., et al. Risks and benefits of fish consumption for childbearing women. Can. J. Diet Pract. Res. 2010, 71(1):41-45.
42. Denomme J., Stark K.D., Holub B.J. Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J. Nutr. 2005, 135(2):206-211.
43. Dewailly E.E., et al. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am. J. Clin. Nutr. 2001, 74(5):603-611.
44. Dewailly E., et al. Balancing the risks and the benefits of local fish consumption in Bermuda. Food Addit. Contam. Part A 2008, 25(11):1328-1338.
45. Dietary Guidelines Advisory Committee, 2015. Scientific Report of the 2015 Dietary Guidelines Advisory Committee.
46. Doughman S.D., Krupanidhi S., Sanjeevi C.B. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr. Diab. Rev. 2007, 3(3):198-203.
47. Dyerberg J., et al. Bioavailability of marine n-3 fatty acid formulations. Prostagland. Leukot. Essen. Fatty Acid. 2010, 83(3):137-141.
48. EFSA Panel on Dietetic Products, 2010. Nutrition, and Allergies (NDA), Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J., 83.
49. Elkin R.G., Ying Y., Harvatine K.J. Feeding laying hens stearidonic acid-enriched soybean oil, as compared to flaxseed oil, more efficiently enriches eggs with very long-chain n-3 polyunsaturated fatty acids. J. Agric. Food Chem. 2015, 63(10):2789-2797.
50. Ervin R.B., et al. Dietary intake of fats and fatty acids for the United States population: 1999-2000. Adv. Data 2004, 348:1-6.
51. Ezaki O., et al. Dietary Reference Intakes for Japanese 2010: Fat. J. Nutr. Sci. Vitaminol. 2012, 59(Supplement):S44-S52.
52. FAO, 2000. The State of World Fisheries and Aquaculture - 2000: Rome.
53. FAO, 2012. The state of world fisheries and aquaculture - 2012: Rome.
54. FAO, 2014. The state of the world fisheries and aquaculture - 2014: Rome.
55. Flock M.R., et al. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults. Prostagland. Leukot. Essen. Fatty Acid. 2014, 91(4):161-168.
56. Flores H., et al. Impact of climate change on Antarctic krill. Mar. Ecol. Prog. Ser. 2012, 458:1-19.
57. Food Safety Authority of Ireland, 2002. Dioxins, Furans and PCBs in Farmed and Wild Salmon, Farmed Trout and Fish Oil Capsules - Summary of Investigation.
58. Foran S.E., Flood J.G., Lewandrowski K.B. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?. Arch. Pathol. Lab. Med. 2003, 127(12):1603-1605.
59. Gallagher M.L., McLeod S.H., Rulifson R. Seasonal variations in fatty acids of striped bass Morone saxatilis. J. World Aquaculture Soc. 1989, 20(2):38-45.
60. Gebauer S.K., et al. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am. J. Clin. Nutr. 2006, 83(6 (Suppl.)):1526S-1535S.
61. Geppert J., et al. Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 2005, 40(8):807-814.
62. Ghasemifard S., Turchini G.M., Sinclair A.J. Omega-3 long chain fatty acid "bioavailability": a review of evidence and methodological considerations. Prog. Lipid Res. 2014, 56:92-108.
63. GISSI-Prevenzione Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. The Lancet 1999, 354(9177):447-455.
64. Givens D., Gibbs R. Very long chain n-3 polyunsaturated fatty acids in the food chain in the UK and the potential of animal-derived foods to increase intake. Nutr. Bull. 2006, 31(2):104-110.
65. GlaxoSmithKline, 2014. Lovaza: highlights of prescribing information.
66. Granada L., et al. Is integrated multitrophic aquaculture the solution to the sectors' major challenges?-a review. Rev. Aquacult. 2015, 1-18.
67. Grandjean P., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol. Teratol. 1997, 19(6):417-428.
68. Greiner A., Clegg Smith K., Guallar E. Something fishy? News media presentation of complex health issues related to fish consumption guidelines. Public Health Nutr. 2010, 13(11):1786-1794.
69. Guil-Guerrero J.L., García Maroto F.F., Giménez Giménez A. Fatty acid profiles from forty-nine plant species that are potential new sources of ?-linolenic acid. J. Amer Oil Chem. Soc. 2001, 78(7):677-684.
70. Handå A., et al. Incorporation of fish feed and growth of blue mussels (Mytilus edulis) in close proximity to salmon (Salmo salar) aquaculture: Implications for integrated multi-trophic aquaculture in Norwegian coastal waters. Aquaculture 2012, 356-357:328-341.
71. Hardy R.W., Lee C. Aquaculture feed and seafood quality. Bull. Fish Res. Agen. 2010, 31:43-50.
72. Harris W.S. n-3 Fatty acid fortification: opportunities and obstacles. Br. J. Nutr. 2007, 97(04):593-595.
73. Harris W.S. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol. Res. 2007, 55(3):217-223.
74. Harris W.S. You are what you eat applies to fish, too. J. Am. Dietetic Assoc. 2008, 108(7):1131-1133.
75. Harris W.S. Achieving optimal n-3 fatty acid status: the vegetarian's challenge or not. Am. J. Clin. Nutr. 2014, 100(1 (Suppl.)):449S-452S.
76. Harris W.S., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110(12):1645-1649.
77. Harris W.S., et al. Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 2008, 43(9):805-811.
78. Harris W.S., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J. Nutr. 2009, 139(4):804S-819S.
79. Health Council of the Netherlands, 2001. Dietary reference intakes: energy, proteins, fats, and digestible carbohydrates. Health Council of the Netherlands: The Hague.
80. Herber S.M., Van Elswyk M.E. Dietary marine algae promotes efficient deposition of n-3 fatty acids for the production of enriched shell eggs. Poult. Sci. 1996, 75(12):1501-1507.
81. Howe P.R., et al. Tuna fishmeal as a source of DHA for n-3 PUFA enrichment of pork, chicken, and eggs. Lipids 2002, 37(11):1067-1076.
82. Howe P.R., et al. Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 2006, 22(1):47-53.
83. Howe P.R., Buckley J., Meyer B. Long-chain omega-3 fatty acids in red meat. Nutr. Dietetic. 2007, 64:S135-S139.
84. Innis S.M. Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv. Exp. Med. Biol. 2004, 554:27-43.
85. Innis S.M. Dietary (n-3) fatty acids and brain development. J. Nutr. 2007, 137(4):855-859.
86. Innis S.M. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008, 1237:35-43.
87. Innis S.M., Elias S.L. Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women. Am. J. Clin. Nutr. 2003, 77(2):473-478.
88. Institute of Medicine, 2005. Food and Nutrition Board, Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC.
89. Jacobs M.N., Covaci A., Schepens P. Investigation of selected persistent organic pollutants in farmed Atlantic salmon (Salmo salar), salmon aquaculture feed, and fish oil components of the feed. Environ. Sci. Technol. 2002, 36(13):2797-2805.
90. Jacobson T.A., et al. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. J. Clin. Lipidol. 2012, 6(1):5-18.
91. James M.J., Ursin V.M., Cleland L.G. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am. J. Clin. Nutr. 2003, 77(5):1140-1145.
92. Jenkins D.J., et al. Are dietary recommendations for the use of fish oils sustainable?. CMAJ 2009, 180(6):633-637.
93. Jia X., et al. Women who take n-3 long-chain polyunsaturated fatty acid supplements during pregnancy and lactation meet the recommended intake. Appl. Physiol. Nutr. Metab. 2015, 40(5):474-481.
94. Jobling M., Bendiksen E.Å. Dietary lipids and temperature interact to influence tissue fatty acid compositions of Atlantic salmon, Salmo salar L., parr. Aquaculture Res. 2003, 34(15):1423-1441.
95. Joint FAO/WHO Expert Consulation, 2010. Fats and fatty acids in human nutrition - Report of an expert consulation: Geneva, Switzerland.
96. Joint FAO/WHO Expert Consulation, 2010. Risks and Benefits of Fish Consumption: Rome.
97. Jones T.O., Iwama G.K. Polyculture of the Pacific oyster, Crassostrea gigas (Thunberg), with chinook salmon Oncorhynchus tshawytscha. Aquaculture 1991, 92:313-322.
98. Kang J.X., et al. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427(6974):504.
99. Kastelein J.J., et al. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. J. Clin. Lipidol. 2014, 8(1):94-106.
100. Katan M.B., et al. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 1997, 38(10):2012-2022.
101. Kaur G., et al. Short-term docosapentaenoic acid (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats. Br. J. Nutr. 2010, 103(1):32-37.
102. Kaur G., et al. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog. Lipid Res. 2011, 50(1):28-34.
103. Kennedy E.T., Luo H., Ausman L.M. Cost implications of alternative sources of (n-3) fatty acid consumption in the United States. J. Nutr. 2012, 142(3):605S-609S.
104. Kingsbury K.J., et al. Effects of ethyl arachidonate, cod-liver oil, and corn oil on the plasma-cholesterol level. A comparison in normal volunters. Lancet 1961, 1(7180):739-741.
105. Koletzko B., Rodriguez-Palmero M. Polyunsaturated fatty acids in human milk and their role in early infant development. J. Mammary Gland Biol. Neoplasia 1999, 4(3):269-284.
106. Koletzko B., Cetin I., Brenna J.T. Dietary fat intakes for pregnant and lactating women. Br. J. Nutr. 2007, 98(5):873-877.
107. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757.
108. Kris-Etherton P.M., et al. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J. Am. Diet Assoc. 2007, 107(9):1599-1611.
109. Krkosek M., et al. Declining wild salmon populations in relation to parasites from farm salmon. Science 2007, 318(5857):1772-1775.
110. Krokan H.E., Bjerve K.S., Mork E. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. Biochem. Biophys. Acta 1993, 1168(1):59-67.
111. Krul E.S., et al. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostagland. Leukot. Essen. Fatty Acid. 2012, 86(1-2):51-59.
112. Kuhnt K., et al. Searching for health beneficial n-3 and n-6 fatty acids in plant seeds. Eur. J. Lipid Sci. Technol. 2012, 114(2):153-160.
113. Kuratko C.N., Salem N. Docosahexaenoic acid from algal oil. Eur. J. Lipid Sci. Technol. 2013, 115(9):965-976.
114. Kwantes J.M., Grundmann O. A brief review of krill oil history, research, and the commercial market. J. Dietary Suppl. 2015, 12(1):23-35.
115. Labonte M.E., et al. Association of red blood cell n-3 polyunsaturated fatty acids with plasma inflammatory biomarkers among the Quebec Cree population. Eur. J. Clin. Nutr. 2014, 68(9):1042-1047.
116. Lai L., et al. Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat. Biotechnol. 2006, 24(4):435-436.
117. Lawson L.D., Hughes B.G. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem. Biophy. Res. Commun. 1988, 152(1):328-335.
118. Lemke S.L., et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am. J. Clin. Nutr. 2010, 92(4):766-775.
119. Lentjes M.A., et al. Cod liver oil supplement consumption and health: cross-sectional results from the EPIC-Norfolk cohort study. Nutrients 2014, 6(10):4320-4337.
120. Leskanich C., Noble R. Manipulation of the n-3 polyunsaturated fatty acid composition of avian eggs and meat. World's Poultry Sci. J. 1997, 53(02):155-183.
121. Linseisen J., et al. Quantity and quality of dietary fat, carbohydrate, and fiber intake in the German EPIC cohorts. Ann. Nutr. Metab. 2003, 47(1):37-46.
122. Lloyd-Jones D.M., et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010, 121(4):586-613.
123. Mahaffey K.R., et al. Balancing the benefits of n-3 polyunsaturated fatty acids and the risks of methylmercury exposure from fish consumption. Nutr. Rev. 2011, 69(9):493-508.
124. Mandell I.B., et al. Effects of fish meal in beef cattle diets on growth performance, carcass characteristics, and fatty acid composition of longissimus muscle. J. Anim. Sci. 1997, 75(4):910-919.
125. Meyer B.J., Lane A.E., Mann N.J. Comparison of seal oil to tuna oil on plasma lipid levels and blood pressure in hypertriglyceridaemic subjects. Lipids 2009, 44(9):827-835.
126. Micallef M.A., Munro I.A., Garg M.L. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur. J. Clin. Nutr. 2009, 63(9):1154-1156.
127. Miller E., et al. A short-term n-3 DPA supplementation study in humans. Eur. J. Nutr. 2013, 52(3):895-904.
128. Mori T.A., Woodman R.J. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9(2):95-104.
129. Mori T.A., et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71(5):1085-1094.
130. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296(15):1885-1899.
131. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 2011, 58(20):2047-2067.
132. Mozaffarian D., Wu J.H. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?. J. Nutr. 2012, 142(3):614S-625S.
133. Mozaffarian D., et al. Circulating long-chain omega-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann. Intern Med. 2011, 155(3):160-170.
134. Mozaffarian D., et al. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann. Intern Med. 2013, 158(7):515-525.
135. Murphy K.J., et al. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br. J. Nutr. 2007, 97(4):749-757.
136. Myers G.J., et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. The Lancet 2003, 361(9370):1686-1692.
137. Napier J.A., et al. Transgenic plants as a sustainable, terrestrial source of fish oils. Eur. J. Lipid Sci. Technol. 2015, 1317-1324.
138. National Fisheries Institute, 2013. Top 10 Consumed Seafoods. https://www.aboutseafood.com/about/about-seafood/top-10-consumed-seafoods.
139. National Institute for Health and Care Excellence, 2014. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease, in NICE clinical guideline 181.
140. Naylor R.L., et al. Nature's subsidies to shrimp and salmon farming. Science 1998, 282(5390):883.
141. Naylor R.L., et al. Effect of aquaculture on world fish supplies. Nature 2000, 405(6790):1017-1024.
142. Neori A., et al. Seaweed biofilters as regulators of water quality in integrated fish-seaweed culture units. Aquaculture 1996, 141(3-4):183-199.
143. Neori A., et al. Integrated aquaculture: rationale, evolution and state of the art emphasizing seaweed biofiltration in modern mariculture. Aquaculture 2004, 231(1-4):361-391.
144. Neubronner J., et al. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. Eur. J. Clin. Nutr. 2011, 65(2):247-254.
145. Nicol S., Foster J., Kawaguchi S. The fishery for Antarctic krill-recent developments. Fish Fisher. 2012, 13(1):30-40.
146. Nordoy A., et al. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am. J. Clin. Nutr. 1991, 53(5):1185-1190.
147. Norris P.C., Dennis E.A. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl. Acad. Sci. USA 2012, 109(22):8517-8522.
148. Nuernberg K., et al. Effect of a grass-based and a concentrate feeding system on meat quality characteristics and fatty acid composition of longissimus muscle in different cattle breeds. Livestock Prod. Sci. 2005, 94(1):137-147.
149. Oda E., et al. A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction. Int. Heart J. 2005, 46(4):583-591.
150. Oken E., et al. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet. Gynecol. 2003, 102(2):346-351.
151. Oken E., et al. Which fish should I eat? Perspectives influencing fish consumption choices. Environ. Health Perspect. 2012, 120(6):790-798.
152. Papanikolaou Y., et al. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008. Nutr. J. 2014, 13:31.
153. Patil V., et al. Fatty acid composition of 12 microalgae for possible use in aquaculture feed. Aquaculture Int. 2007, 15(1):1-9.
154. Pauly D., Watson R., Alder J. Global trends in world fisheries: impacts on marine ecosystems and food security. Philos. Trans. R Soc. London B 2005, 360(1453):5-12.
155. Petrie J.R., et al. Metabolic engineering Camelina sativa with fish oil-like levels of DHA. PLoS One 2014, 9(1):e85061.
156. Pieters D.J., Mensink R.P. Effects of stearidonic acid on serum triacylglycerol concentrations in overweight and obese subjects: a randomized controlled trial. Eur. J. Clin. Nutr. 2015, 69(1):121-126.
157. Ponnampalam E.N., Mann N.J., Sinclair A.J. Effect of feeding systems on omega-3 fatty acids, conjugated linoleic acid and trans fatty acids in Australian beef cuts: potential impact on human health. Asia Pac. J. Clin. Nutr. 2006, 15(1):21-29.
158. Rahmawaty S., et al. Dietary intake and food sources of EPA, DPA and DHA in Australian children. Lipids 2013, 48(9):869-877.
159. Reinders I., et al. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur. J. Clin. Nutr. 2012, 66(6):736-741.
160. Rubio-Rodríguez N., et al. Production of omega-3 polyunsaturated fatty acid concentrates: a review. Innovativ. Food Sci. Emerg. Technol. 2010, 11(1):1-12.
161. Ruxton C.H.S. The benefits of fish consumption. Nutr. Bull. 2011, 36(1):6-19.
162. Salem N., Eggersdorfer M. Is the world supply of omega-3 fatty acids adequate for optimal human nutrition?. Curr. Opin. Clin. Nutr. Metab. Care 2015, 18(2):147-154.
163. Salem N., Kuratko C.N. A reexamination of krill oil bioavailability studies. Lipids Health Dis. 2014, 13.
164. Samocha T.M., et al. Growth and nutrient uptake of the macroalga Gracilaria tikvahiae cultured with the shrimp Litopenaeus vannamei in an Integrated Multi-Trophic Aquaculture (IMTA) system. Aquaculture 2015, 446:263-271.
165. Sanders T.A. DHA status of vegetarians. Prostagland. Leukotrien. Essen. Fatty Acid. 2009, 81(2):137-141.
166. Sanders T.A., Vickers M., Haines A.P. Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men. Clin. Sci. (London) 1981, 61(3):317-324.
167. Sayanova O., Napier J.A. Transgenic oilseed crops as an alternative to fish oils. Prostagland. Leukot. Essent. Fatty Acid. 2011, 85(5):253-260.
168. Schuchardt J.P., Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostagland. Leukot. Essent. Fatty Acid. 2013, 89(1):1-8.
169. Scollan N., et al. Innovations in beef production systems that enhance the nutritional and health value of beef lipids and their relationship with meat quality. Meat Sci. 2006, 74(1):17-33.
170. Ser P.H., Watanabe C. Fish advisories in the USA and Japan: risk communication and public awareness of a common idea with different backgrounds. Asia Pac. J. Clin. Nutr. 2012, 21(4):487-494.
171. Shimshack J.P., Ward M.B. Mercury advisories and household health trade-offs. J. Health Econ. 2010, 29(5):674-685.
172. Shimshack J.P., Ward M.B., Beatty T.K.M. Mercury advisories: information, education, and fish consumption. J. Environ. Econ. Manage. 2007, 53(2):158-179.
173. Simopoulos A.P. Summary of the NATO advanced research workshop on dietary omega 3 and omega 6 fatty acids: biological effects and nutritional essentiality. J. Nutr. 1989, 119(4):521-528.
174. Sioen I.A., et al. Dietary intakes and food sources of fatty acids for Belgian women, focused on n-6 and n-3 polyunsaturated fatty acids. Lipids 2006, 41(5):415-422.
175. Sioen L.A., et al. The influence of n-3 PUFA supplements and n-3 PUFA enriched foods on the n-3 LC PUFA intake of Flemish women. Lipids 2010, 45(4):313-320.
176. Skulas-Ray A.C., et al. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin. Pharmacother. 2008, 9(7):1237-1248.
177. Skulas-Ray A.C., et al. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am. J. Clin. Nutr. 2011, 93(2):243-252.
178. Skulas-Ray A.C., et al. Red Blood Cell Docosapentaenoic Acid (DPA n-3) is inversely associated with triglycerides and C-reactive protein (CRP) in healthy adults and dose-dependently increases following n-3 fatty acid supplementation. Nutrients 2015, 7(8):5291.
179. Soto D., Mena G. Filter feeding by the freshwater mussel, Diplodon chilensis, as a biocontrol of salmon farming eutrophication. Aquaculture 1999, 171(1-2):65-81.
180. Spolaore P., et al. Commercial applications of microalgae. J. Biosci. Bioeng. 2006, 101(2):87-96.
181. Sugano M., Hirahara F. Polyunsaturated fatty acids in the food chain in Japan. Am. J. Clin. Nutr. 2000, 71(1 Suppl.):189S-196S.
182. Sun Q., et al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am. J. Clin. Nutr. 2008, 88(1):216-223.
183. Surette M.E. Dietary omega-3 PUFA and health: stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils. Mol. Nutr. Food Res. 2013, 57(5):748-759.
184. Tacon, A., Feeding tomorrow's fish: keys for sustainability. Feeding Tomorrow's Fish. In: Cahiers Options Mediterraneennes, Tacon, A.G.J. and Basurco, B. (Eds.), 1997. 22: p. 11-33.
185. Tatarczyk T., et al. Analysis of long-chain omega-3 fatty acid content in fish-oil supplements. Wien Klin Wochenschr 2007, 119(13-14):417-422.
186. Tavazzi L., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9645):1223-1230.
187. Theophilus Olayiwola B., et al. Differential effects of dietary lipids on growth performance, digestibility, fatty acid composition and histology of African catfish (Heterobranchus longifilis) fingerlings. Food Nutr. Sci. 2011, 2011.
188. Tou J.C., Jaczynski J., Chen Y. Krill for human consumption: nutritional value and potential health benefits. Nutr. Rev. Washington 2007, 65(2):63.
189. Trivelpiece W.Z., et al. Variability in krill biomass links harvesting and climate warming to penguin population changes in Antarctica. Proc. Natl. Acad Sci. USA 2011, 108(18):7625-7628.
190. Troell M., et al. Ecological engineering in aquaculture: use of seaweeds for removing nutrients from intensive mariculture. J.Appl. Phycol. 1999, 11(1):89-97.
191. Truksa M., et al. Metabolic engineering of plants to produce very long-chain polyunsaturated fatty acids. Transgenic Res. 2006, 15(2):131-137.
192. Turner T.D., et al. Comparison of fatty acids in beef tissues from conventional, organic and natural feeding systems in western Canada. Can. J. Animal Sci. 2015, 95(1):49-58.
193. US Food and Drug Administration and Environmental Protection Agency, 2014. Fish: what pregnant women and parents should know.
194. US Food and Drug Administration and Environmental Protection Agency, 2004. Consumer advisory: What you need to know about mercury in fish and shellfish.
195. Ulven S.M., et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46(1):37-46.
196. Ursin V.M. Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J. Nutr. 2003, 133(12):4271-4274.
197. United States Department of Agriculture and United States Department of Health and Human Services (USDA, HSS), Dietary Guidelines for Americans, 2010. 2010, US Government Printing Office: Washington, DC.
198. Vannice G., Rasmussen H. Position of the academy of nutrition and dietetics: dietary fatty acids for healthy adults. J. Acad. Nutr. Diet 2014, 114(1):136-153.
199. Verbeke W., et al. Consumer perception versus scientific evidence about health benefits and safety risks from fish consumption. Public Health Nutr. 2005, 8(4):422-429.
200. von Schacky C., Weber P.C. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest. 1985, 76(6):2446-2450.
201. Wachira A.M., et al. Effects of dietary fat source and breed on the carcass composition, n-3 polyunsaturated fatty acid and conjugated linoleic acid content of sheep meat and adipose tissue. Br. J. Nutr. 2002, 88(6):697-709.
202. Walker C.G., Jebb S.A., Calder P.C. Stearidonic acid as a supplemental source of omega-3 polyunsaturated fatty acids to enhance status for improved human health. Nutrition 2013, 29(2):363-369.
203. Ward O.P., Singh A. Omega-3/6 fatty acids: alternative sources of production. Process Biochem. 2005, 40(12):3627-3652.
204. Weaver K.L., et al. The content of favorable and unfavorable polyunsaturated fatty acids found in commonly eaten fish. J. Am. Diet Assoc. 2008, 108(7):1178-1185.
205. Wei M.Y., Jacobson T.A. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr. Atheroscler. Rep. 2011, 13(6):474-483.
206. Whelan J. Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. J. Nutr. 2009, 139(1):5-10.
207. Whelan J., Rust C. Innovative dietary sources of n-3 fatty acids. Ann. Rev. Nutr. 2006, 26:75-103.
208. Whelan J., Gouffon J., Zhao Y. Effects of dietary stearidonic acid on biomarkers of lipid metabolism. J. Nutr. 2012, 142(3):630S-634S.
209. Yokoyama M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369(9567):1090-1098.
210. Zlatanos S., Laskaridis K. Seasonal variation in the fatty acid composition of three Mediterranean fish-sardine (Sardina pilchardus), anchovy (Engraulis encrasicholus) and picarel (Spicara smaris). Food Chem. 2007, 103(3):725-728.